Copyright
©The Author(s) 2015.
World J Psychiatr. Jun 22, 2015; 5(2): 170-181
Published online Jun 22, 2015. doi: 10.5498/wjp.v5.i2.170
Published online Jun 22, 2015. doi: 10.5498/wjp.v5.i2.170
Table 1 Meta-analytic studies of the antidepressant efficacy of transcranial magnetic stimulation published on or after 2003
Ref. | No. of trials | Mean age | Effect size |
Allan et al[29] 2011 | 25 | Not presented | NNT = 5 |
Berlim et al[22] (bilateral) 2013 | 7 | 49.3 + 5.7 | NNT = 6 (res); 7 (rem) |
Berlim et al[47] (HF) 2013 | 29 | 47.6 + 7.1 | NNT = 6 (res); 8 (rem) |
Berlim et al[21] (LF) 2013 | 8 | 49.39 ± 7.0 | NNT = 5 (res/rem) |
Schutter[25] 2013 (add-on) | 6 | 44.47 ± 7.55 | NNT = 7 |
Couturier[91] 2005 | 6 | Not presented | WMD = 1.1 |
Gaynes et al[76] 2014 | 18 (TRD) | Not presented | NNT = 9 (res); 5 (rem) |
Gross et al[71] 2007 | 5 | 44.7 + 4.2 | d = 0.76 |
Herrmann et al[28] 2006 | 33 | 49.14 (subgroups split at age 50) | d = 0.65 |
Lam et al[92] 2008 | 24 | Not presented | NNT = 6 |
Lepping et al[16] 2014 | 22 (nTRD) | Not presented | d = 0.63 (nTRD) |
10 (TRD) | d = 0.74 (TRD) | ||
Martin et al[20] 2003 | 14 | 41.8 - 60.9 | d = 0.35 |
Schutter[25] 2009 (HF) | 30 | 49.5 + 7.8 | d = 0.39 |
Schutter[26] 2010 (LF) | 9 | 50.0 + 6.3 | d = 0.63 |
Slotema et al[13] 2010 | 40 | Not presented | d = 0.55 |
Kedzior et al[19] 2014 | 14 | 27.0-53.0 | d = 0.42 |
Table 2 Randomised Controlled Trials investigating antidepressant effect of transcranial magnetic stimulation in older subjects (mean age of sample > 60)
Trial | Age range | TMS parameters | Sample size | Methodology | Results |
Manes et al[30] 2001 | 60.7 ± 9.8 | 20 Hz; 80%MT; left DLPFC; 800 pulses/session; 5 sessions; no. of pulses = 4000 | 20 (sham = 10) | Double blind RCT with handle as sham in subjects with one antidepressant failure aged 50-70, withdrawn from antidepressants for 5 d | No sham vs active differences; in each group 30% responded. Non-responders had reduced frontal volume. No drop-outs due to adverse effects |
Mosimann et al[31] 2004 | 62 + 12 | 20 Hz; 100%MT; left DLPFC; 1600 pulses/session; 10 sessions; no. of pulses = 16000 | 24 (sham = 9) | Double blind RCT with tilted-sham in 40-90 years old subjects with TRD | No sham vs active differences |
Jorge et al[32] 2008 (Trial 1) | 62.9 (7.2) | 10 Hz; 110%MT; MRI-based target localisation of left DLPFC; 1200 pulses/session; 10 sessions; no. of pulses = 12000 | 30 (sham = 15) | Double blind RCT with look-alike sham coil in subjects > 50 yr age with vascular depression and failed at least one antidepressant; all patients medication-free for at least 4 d before TMS | Age inversely correlated with response; frontal volume positively correlated with response. Active treatment: 33.3% responders; sham: 6.7% responders. No drop-outs due to adverse events |
Jorge et al[32] 2008 (Trial 2) | 64.3 (9.4) | 10 Hz; 110%MT; MRI-based target localisation of left DLPFC; 1200 pulses/session; 15 sessions; no. of pulses = 18000 | 62 (sham = 29) | Double blind RCT with look-alike sham coil in subjects > 50 yr age with vascular depression and failed at least one antidepressant; all patients medication-free for at least 4 d before TMS | Active treatment: 39.4% responders; sham: 6.9% responders. Older subjects had better response for higher dose. No drop-outs due to adverse events |
Table 3 Uncontrolled studies exploring the effect of age on the antidepressant effect of transcranial magnetic stimulation by recruiting older subjects (mean age of sample > 60) or undertaking analyses in subgroups with mean age > 60
Trial | Age range | TMS parameters | Sample size | Methodology | Results |
Figiel et al[37] 1998 | 60.0 (22-89) | 10 Hz; 110%MT; left DLPFC; 500 pulses/session; 5 sessions; no. of pulses = 2500 | 50 | Uncontrolled trial in patients > 18 yr attending a Mood Disorder Clinic (most referred for ECT) | Age associated with treatment response; < 65 (n = 28) responded better (56%) than > 65 group (n = 22; 23% response). Overall 42% responded after the 5 sessions |
Nahas et al[38] 2004 | 61.2 (7.3) | 5Hz; 103%-141%MT (distance adjusted); left DLPFC; 1600 pulses/session; 15 sessions; no. of pulses = 18000 | 18 | Uncontrolled trial in patients 55-75 yr; not selected for TRD | No correlation between age and response; 27% responded; 22% remitted; No drop-outs due to adverse events |
Fabre et al[35] 2004 | 67.9 (6.7) | 10 Hz; 100%MT; left DLPFC; 1600 pulses/session; 10 sessions; no. of pulses = 16000 | 11 | Uncontrolled trial in patients age > 55 with vascular depression (first episode) and TRD but kept antidepressant free for 1 wk | 5 out of 11 patients had clinically meaningful improvement in HDRS scores; response inversely related to frontal volume. No drop-outs due to adverse events |
Abraham et al[39] 2007 | 66.8 (6.4) | 10 Hz; 100%MT; left DLPFC; 1600 pulses/session; 10 sessions; no. of pulses = 16000 | 20 | Uncontrolled trial in patients > 60 yr attending a specialist clinic - most referred for ECT | 30% responded at the end of treatment; 1 dropout due to discomfort |
Milev et al[78] 2009 | 69.0 (6.7) | Variable parameters: LF (1 Hz, 1200 pulses/session, n = 14), HF (10 Hz, 1600 pulses/session n = 31); both LF and HF (n = 4); 80%-110%MT; right or left DLPFC | 49 | Uncontrolled trial that includes patients with TRD referred to 2 specialist mood disorder clinics; all except 3 medicated | 24.7% mean reduction in HDRS scores; 18% responders; 1 dropout due to discomfort out of 49. (Note: This sample includes n = 20 from Abraham 2007) |
Pallanti et al[33] 2012 | 51.8 (14.1) | 1 Hz; 110%MT; right DLPFC; 420 pulses/session; 15 sessions.; no. of pulses = 6300 | 102 | Uncontrolled trial in consecutively enrolled nonpsychotic subjects in a TMS clinic with TRD | Age inversely related to response especially in patients > 60 yr; overall 56.9% responded. 62.1% of < 60 (n = 66) and 47.2% of > 60 (n = 36) responded at 3 wk. 18.6% drop-outs due to intolerance |
Hizli Sayar et al[36] 2013 | 66.6 (5.8) | 25 Hz; 100%MT; left DLPFC; 1000 pulses/session; 18 sessions; no. of pulses = 18000 | 70 | Uncontrolled trial in patients > 60 yr with TRD | 58.5% responded; 29.2% remitted; No drop-outs due to adverse events |
Ciobanu et al[34] 2013 | 58.7 (14.0) | LF (1 Hz, 1200 pulses/session, n = 80), HF (10 Hz, 2000 pulses/session n = 13); 90%MT; right or left DLPFC; 15 sessions; no. of pulses = 18000 | 93 | Uncontrolled trial in > 18 yr old subjects with TRD | Age not related to response; No difference between < 65 (n = 63; 53.3% responded) and > 65 age (n = 30; 46.7% responded) groups immediately and at 3 mo |
Table 4 Summary of meta-analyses comparing transcranial magnetic stimulation and electroconvulsive therapy in depression
Meta-analysis | No. of studies/sample size | Mean age range | Summary of effect |
Berlim et al[47] 2013 | 7/294 | 31.0-63.6 | NNT = 6 favouring ECT for short-term response; at baseline, ECT samples had shorter illness duration and higher HAMD scores than rTMS samples. Age has no moderating effect on the differences |
Ren et al[46] 2014 | 9/425 | 31.0-63.6 | NNT = 7 for response; 6 for remission favouring ECT; No significant group difference when continuous change in HAMD scores is considered as outcome; In the absence of psychosis, rTMS as efficacious as ECT; Cognitive domains are better preserved after rTMS than ECT |
Micallef-Trigona[49] 2014 | 9/384 | 34.0-63.6 | Hedges’g = 1.28 for rTMS and 2.15 for ECT. rTMS produces a mean reduction of 9.3 points; ECT produces a mean reduction of 15.42 points on the HDRS |
Xie et al[48] 2013 | 9/395 | 31.0-63.6 | OR = 0.55 for response and 0.49 for remission in favour of ECT; rTMS is better tolerated than ECT (OR = 0.70); rTMS > 1200 stimuli/d is as efficacious as ECT |
- Citation: Sabesan P, Lankappa S, Khalifa N, Krishnan V, Gandhi R, Palaniyappan L. Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls. World J Psychiatr 2015; 5(2): 170-181
- URL: https://www.wjgnet.com/2220-3206/full/v5/i2/170.htm
- DOI: https://dx.doi.org/10.5498/wjp.v5.i2.170